Showing 1 - 16 results of 16 for search 'Jean‐Pierre Marolleau', query time: 0.06s
Refine Results
-
1
-
2
P1104: THE PROGNOSTIC ROLE OF DEPTH OF RESPONSE DEPENDS ON THE TIME OF ASSESSMENT AFTER FIRST-LINE IMMUNOCHEMOTHERAPY IN PATIENTS WITH SYMPTOMATIC WALDENSTROM MACROGOBULINEMIA (WM)... by Lydia Montes, Caroline Delette, Daniela Robu, Delphine Lebon, Etienne Paubelle, Jean Pierre Marolleau, Pierre Morel
Published 2023-08-01
Article -
3
Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30 by Lydia Montes, Estelle Tredez, Clara Yzet, Caroline Delette, Denis Chatelain, Delphine Lebon, Mathurin Fumery, Jean‐Pierre Marolleau
Published 2020-06-01
Article -
4
-
5
The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib by Rémy Nyga, Laura Simon, Taieb Chouaki, Caroline Delette, Youssef Bennis, Cedric Joseph, Jean-Pierre Marolleau, Michel Slama, Elie Zogheib, Julien Maizel
Published 2019-03-01
Article -
6
Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia by Walaa Darwiche, Cathy Gomila, Hakim Ouled-Haddou, Marie Naudot, Cécile Doualle, Pierre Morel, Florence Nguyen-Khac, Loïc Garçon, Jean-Pierre Marolleau, Hussein Ghamlouch
Published 2020-10-01
Article -
7
Human Muscle Progenitor Cells Displayed Immunosuppressive Effect through Galectin-1 and Semaphorin-3A by Séverine Lecourt, Yves Lepelletier, Valérie Vanneaux, Rafika Jarray, Thomas Domet, Françoise Raynaud, Réda Hadj-Slimane, Audrey Cras, Olivier Hermine, Jean-Pierre Marolleau, Jérôme Larghero
Published 2012-01-01
Article -
8
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the rando... by Pieternella Lugtenburg, Irit Avivi, Henriette Berenschot, Osman Ilhan, Jean Pierre Marolleau, Arnon Nagler, Antonio Rueda, Monica Tani, Mehmet Turgut, Stuart Osborne, Rodney Smith, Michael Pfreundschuh
Published 2017-11-01
Article -
9
Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults by Laurène Fenwarth, Alexis Caulier, Emma Lachaier, Laure Goursaud, Alice Marceau-Renaut, Elise Fournier, Delphine Lebon, Thomas Boyer, Céline Berthon, Jean-Pierre Marolleau, Claude Preudhomme, Nicolas Duployez
Published 2021-04-01
Article -
10
PB1769: STIM2, A CALCIUM CENSOR POTENTIALLY INVOLVED IN THE PATHOPHYSIOLOGY OF ACUTE MYELOID LEUKEMIA by Stefan Djordjevic, Delphine Lebon, Raphael Itzykson, Hakim Ouled-Haddou, Nicolas Duployer, Juliette Harbonnier, Louison Collet, Etienne Paubelle, Guillaume Jedraszak, Jean Pierre Marolleau, Thomas Boyer, Loic Garcon
Published 2023-08-01
Article -
11
STIM2 is involved in the regulation of apoptosis and the cell cycle in normal and malignant monocytic cells by Stefan Djordjevic, Raphaël Itzykson, Frédéric Hague, Delphine Lebon, Julien Legrand, Hakim Ouled‐Haddou, Guillaume Jedraszak, Juliette Harbonnier, Louison Collet, Etienne Paubelle, Jean‐Pierre Marolleau, Loïc Garçon, Thomas Boyer
Published 2024-06-01
Article -
12
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients. by Séverine Lecourt, Enguerran Mouly, Delphine Freida, Audrey Cras, Raphaël Ceccaldi, Djazia Heraoui, Christine Chomienne, Jean-Pierre Marolleau, Bertrand Arnulf, Raphael Porcher, Catherine Caillaud, Valérie Vanneaux, Nadia Belmatoug, Jérôme Larghero
Published 2013-01-01
Article -
13
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a repor... by Ramy Rahmé, Lionel Ades, Xavier Thomas, Agnès Guerci-Bresler, Arnaud Pigneux, Norbert Vey, Emmanuel Raffoux, Sylvie Castaigne, Olivier Spertini, Sebastian Wittnebel, Jean Pierre Marolleau, Gandhi Damaj, Dominique Bordessoule, Julie Lejeune, Sylvie Chevret, Pierre Fenaux
Published 2018-11-01
Article -
14
Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study by Axel André, Lydia Montes, Damien Roos‐Weil, Laurent Frenzel, Marguerite Vignon, Thomas Chalopin, Pierre‐Edouard Debureaux, Alexis Talbot, Agathe Farge, Fabrice Jardin, Karim Belhadj, Bruno Royer, Jean‐Pierre Marolleau, Bertrand Arnulf, Pierre Morel, Stéphanie Harel
Published 2024-08-01
Article -
15
PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells by Alexis Caulier, Nicolas Jankovsky, Yohann Demont, Hakim Ouled-Haddou, Julien Demagny, Corinne Guitton, Lavinia Merlusca, Delphine Lebon, Pascal Vong, Aurélien Aubry, Agnès Lahary, Christian Rose, Sandrine Gréaume, Emilie Cardon, Jessica Platon, Halima Ouadid-Ahidouch, Jacques Rochette, Jean-Pierre Marolleau, Véronique Picard, Loïc Garçon
Published 2020-03-01
Article -
16
Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma by Anais Schavgoulidze, Valerie Lauwers-Cances, Aurore Perrot, Titouan Cazaubiel, Marie-Lorraine Chretien, Philippe Moreau, Thierry Facon, Xavier Leleu, Lionel Karlin, Anne-Marie Stoppa, Olivier Decaux, Karim Belhadj, Bertrand Arnulf, Mohamad Mohty, Clara M ariette, Cecile Fohrer-Sonntag, Pascal Lenain, Jean-Pierre Marolleau, Mourad Tiab, Carla Araujo, Frederique Orsini-Piocelle, Arnaud Jaccard, Murielle Roussel, Lotfi Benboubker, Jean-Richard Eveillard, Mamoun Dib, Marion Divoux, Michel Attal, Herve Avet-Loiseau, Jill Corre
Published 2022-09-01
Article